Netherlands· NL-27b75dff30a8

Buprenorfine Teva 35 microgram/uur 4 dagen, pleister voor transdermaal gebruik

A buprenorphine product containing buprenorfine, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC N02AE01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about buprenorfineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Buprenorphine is registered in 13 of 19 countries.

Countries holding a registration under ATC N02AE01 (buprenorphine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search buprenorphine products by name

Buprenorphine · ATC N02AE01

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of buprenorphine costs, country by country.

Normalised to the WHO defined daily dose (1.2 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Buprenorphine · price per daily dose (1.2 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.77

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: BUPRENORFINE
Manufacturer: Teva Nederland B.V.
Country: Netherlands (NL)
ATC code: N02AE01
ATC class: Buprenorphine
Defined daily dose: 1.2 mg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
116173

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

378 interactions on record for buprenorphine.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check buprenorphine against other medicines How interaction checks work

Buprenorphine · interactions on record

378 records

59 severe
253 moderate
2 minor
52 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
DronabinolA04AD10severe

12 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Buprenorphine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All buprenorphine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Astec, Bupensan
Belgium · Temgesic, Transtec
Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
Cyprus · Buvera
Czechia · Addnok, Buprenorfin Stada
Germany · Acimaphin, Acinorphin
Denmark · Buprefarm, Bupremyl
Estonia · Buprenorphine G.L. Pharma
Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
Finland · Buprefarm, Bupremyl
France · Bupensan, Buprenorphine Arrow
United Kingdom (Northern Ireland) · Addnok, Bunov
Greece · Buprenal, Buvera
Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
Ireland · Buprenorphine Activase Pharmaceuticals, Buprenorphine Morningside Healthcare
Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
Italy · Buprenorfina Molteni, Buprenorfina Sandoz
Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
Luxembourg · Temgesic, Temgesic Sublingualis
Latvia · Buprenorphine G.L. Pharma
Malta · Buprenorphine Aspire Pharma (Malta), Natzon
Norway · Bugnanto, Buprefarm
Poland · Bunondol, Bunorfin
Portugal · Buprenorfina, Buprenorfina Aurovitas
Sweden · Buprefarm, Buprenorfin Actavis
Slovenia · Addnok, Buprenorfin Alkaloid-Int
Slovakia · Bupretec, Noprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fc4e5193-7b0e-4b76-8635-7ee004211936
GET /v1/drugs/fc4e5193-7b0e-4b76-8635-7ee004211936?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pleister voor transdermaal gebruik",
  "route": "Transdermaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h116173_smpc.pdf",
  "strength": null,
  "atc_label": "Buprenorphine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg116173",
  "excipients": [
    "BLAUWE INKT",
    "COPOLYMEER VAN 2-ETHYLHEXYLACRYLAAT (75,0), BUTYLACRYLAAT (15,0), ACRYLZUUR (5,0), VINYLACETAAT (5,0) MET ALUMINIUMACETYLACETONAAT ALS CROSSLINKINGAGENT",
    "COPOLYMEER VAN 2-ETHYLHEXYLACRYLAAT, GLYCIDYLMETHACRYLAAT, HYDROXYETHYLACRYLAAT, VINYLACETAAT",
    "LEVULINEZUUR",
    "OLEYLOLEAAT",
    "POLYESTER",
    "POLYETHYLEENTEREPHTHALAAT",
    "POLYETHYLEENTEREPHTHALAAT, GESILICONEERD",
    "POVIDON K 90 (E 1201)"
  ],
  "substances": [
    "BUPRENORFINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h116173.pdf",
  "authorised_at": "2016/03/01",
  "procedure_number": "DE/H/5078/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "116173",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about buprenorphine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console